Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].

× No keyword cloud information.

36 in total

1. A rationally derived MMPI scale to measure dependence.

Authors: L NAVRAN
Journal: J Consult Psychol Date: 1954-06

2. [Advantages of the combination therapy (L-Dopa and decarboxylase inhibitors) in parkinsonism].

Authors: B Gattringer; H Steinhäusl
Journal: Wien Med Wochenschr Date: 1972-06-17

3. Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.

Authors: U K Rinne; V Sonninen; T Sirtola
Journal: Z Neurol Date: 1972

Review 4. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].

Authors: A Pletscher; G Bartholini; K F Gey; A Jenni
Journal: Schweiz Med Wochenschr Date: 1970-05-09

5. [Experimental results of the combined treatment of parkinsonism using L-DOPA and a decarboxylase inhibitory agent (Ro 4-4602)].

Authors: W Birkmayer
Journal: Wien Klin Wochenschr Date: 1969-09-26 Impact factor: 1.704

6. [Treatment of parkinsonism with L-Dopa associated with decarboxylase inhibitors. II].

Authors: G Gauthier; J de Ajuriaguerra; B Simona; J Constantinidis; J J Eisenring; M Krassoievitch; G Yanniotis; R Tissot
Journal: Rev Neurol (Paris) Date: 1970-11 Impact factor: 2.607

7. Intellectual changes associated with levodopa therapy.

Authors: M J Meier; W E Martin
Journal: JAMA Date: 1970-07-20 Impact factor: 56.272

8. [Advances in L-DOPA therapy for parkinsonism through combination with a decarboxylase inhibitor. Results of a long-term study].

Authors: U Wälzholz; H Schönfelder
Journal: Nervenarzt Date: 1972-10 Impact factor: 1.214

9. [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors: W BIRKMAYER; O HORNYKIEWICZ
Journal: Wien Klin Wochenschr Date: 1961-11-10 Impact factor: 1.704

10. Treatment of Parkinsonism with Laevo-dopa.

Authors: C Mawdsley
Journal: Br Med J Date: 1970-02-07

4 in total

1. [Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

Authors: W Gehlen
Journal: Arch Psychiatr Nervenkr (1970) Date: 1974-04-09

Review 2. Cystathionine-β-Synthase: Molecular Regulation and Pharmacological Inhibition.

Authors: Karim Zuhra; Fiona Augsburger; Tomas Majtan; Csaba Szabo
Journal: Biomolecules Date: 2020-04-30

Review 3. Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Authors: R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal: Drugs Date: 1976 Impact factor: 9.546

4. Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.

Authors: U K Rinne; E Birket-Smith; E Dupont; E Hansen; M Hyyppä; R Marttila; B Mikkelsen; H Pakkenberg; J Presthus
Journal: J Neurol Date: 1975-12-02 Impact factor: 4.849

4 in total